Company Overview of Abraxis BioScience, Inc.
Abraxis BioScience, Inc. develops and delivers therapeutics and technologies for patients treatments for cancer and other critical illnesses. The company was formerly known as New Abraxis, Inc. and changed its name to Abraxis Bioscience, Inc. in November 2007. Abraxis BioScience, Inc. was incorporated in 2001 and is based in Los Angeles, California. As of October 15, 2010, Abraxis BioScience, Inc. operates as a subsidiary of Celgene Corporation.
11755 Wilshire Boulevard
Los Angeles, CA 90025
Founded in 2001
Key Executives for Abraxis BioScience, Inc.
Similar Private Companies By Industry
|Arteriocyte, Inc.||United States|
|Centocor Ortho Biotech Services LLC||United States|
|Wyeth Pharmaceuticals, Inc.||United States|
|Ayurcore, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York, NY | AstraZenecaPosted: Dec 03
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
- Detroit, MI | AstraZenecaPosted: Dec 03
Sponsored Financial Commentaries
To contact Abraxis BioScience, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.